IDIOPATHIC INFLAMMATORY MYOPATHY (IIM)
Clinical trials for IDIOPATHIC INFLAMMATORY MYOPATHY (IIM) explained in plain language.
Never miss a new study
Get alerted when new IDIOPATHIC INFLAMMATORY MYOPATHY (IIM) trials appear
Sign up with your email to follow new studies for IDIOPATHIC INFLAMMATORY MYOPATHY (IIM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New 'Smart' drug aims to tame stubborn autoimmune diseases
Disease control Recruiting nowThis early-stage study tests the safety of a new drug called CC312 in up to 18 adults with autoimmune diseases like lupus or rheumatoid arthritis that haven't improved with standard treatments. CC312 works like a bridge, guiding the body's immune cells to attack and destroy fault…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHY (IIM)
Phase: EARLY_PHASE1 • Sponsor: CytoCares Inc • Aim: Disease control
Last updated May 17, 2026 02:21 UTC
-
Experimental CAR-T therapy targets rare muscle disease
Disease control Recruiting nowThis early-phase study tests an experimental cell therapy called GC012F in 12 people with refractory idiopathic inflammatory myopathy, a rare autoimmune disease causing muscle weakness and inflammation. Participants receive a single infusion of their own modified immune cells aft…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHY (IIM)
Phase: EARLY_PHASE1 • Sponsor: Daishi Tian • Aim: Disease control
Last updated May 17, 2026 02:18 UTC
-
CAR t cells take on autoimmune diseases in first human trial
Disease control Recruiting nowThis early-phase study tests a new treatment called HBI0101 CAR T for people with severe autoimmune diseases like lupus, multiple sclerosis, and rheumatoid arthritis that haven't improved with standard care. The treatment uses a patient's own immune cells, modified to target and …
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHY (IIM)
Phase: PHASE1 • Sponsor: Polina Stepensky • Aim: Disease control
Last updated May 17, 2026 02:05 UTC
-
Immune cell therapy shows promise for tough autoimmune cases
Disease control Recruiting nowThis study tests a new treatment using specially engineered immune cells (CAR-NK) for people with severe autoimmune diseases like lupus, scleroderma, and vasculitis that haven't responded to standard therapies. The treatment aims to control the overactive immune system and reduce…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHY (IIM)
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
Blood test could end guesswork in treating arthritis and autoimmune diseases
Diagnosis Recruiting nowThis study is testing a new blood test that may help doctors choose the most effective drug for each person with rheumatic diseases like rheumatoid arthritis or lupus. The test looks at how a person's immune cells react to different medications before treatment starts. The goal i…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHY (IIM)
Sponsor: University of Bonn • Aim: Diagnosis
Last updated May 06, 2026 16:15 UTC